UNIVERSAL HEALTH REALTY INCOME TRUST
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| UNIVERSAL HEALTH REALTY INCOME TRUST | |
| By: | /S/ Alan B. Miller |
| Alan B. Miller,Chairman of the Board,Chief Executive Officer and President |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signatures | Title | Date |
|---|---|---|
| /s/ Alan B. Miller Alan B. Miller | Chairman of the Board, ChiefExecutive Officer and President(Principal Executive Officer) | February 26, 2025 |
| /s/ Gayle L. Capozzalo Gayle L. Capozzalo | Trustee | February 26, 2025 |
| /S/ Michael Allan Domb Michael Allan Domb | Trustee | February 26, 2025 |
| /s/ Rebecca A. Guzman | Trustee | February 26, 2025 |
| Rebecca A. Guzman | ||
| /S/ Robert F. McCadden Robert F. McCadden | Trustee | February 26, 2025 |
| /S/ Marc D. Miller Marc D. Miller | Trustee | February 26, 2025 |
| /S/ James P. Morey James P. Morey | Trustee | February 26, 2025 |
| /S/ Charles F. Boyle Charles F. Boyle | Senior Vice President and Chief Financial Officer(Principal Financial and AccountingOfficer) | February 26, 2025 |
INDEX TO FINANCIAL STATEMENTS AND SCHEDULE
| Page | |
|---|---|
| Consolidated Financial Statements: | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 185) | 53 |
| Consolidated Balance Sheets—December 31, 2024 and December 31, 2023 | 55 |
| Consolidated Statements of Income—Years Ended December 31, 2024, 2023 and 2022 | 56 |
| Consolidated Statements of Comprehensive Income —Years Ended December 31, 2024, 2023 and 2022 | 57 |
| Consolidated Statements of Changes in Equity—Years Ended December 31, 2024, 2023 and 2022 | 58 |
| Consolidated Statements of Cash Flows—Years Ended December 31, 2024, 2023 and 2022 | 59 |
| Notes to the Consolidated Financial Statements | 60 |
| Schedule III—Real Estate and Accumulated Depreciation—December 31, 2024 | 78 |
| Notes to Schedule III—December 31, 2024 | 81 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.